Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Promising trial aims to shrink treatment for kids with hodgkin lymphoma

NCT ID NCT00846742

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study tests a shorter course of chemotherapy (Stanford V) for children and young adults with a favorable type of Hodgkin lymphoma. Those who still have signs of cancer after chemo may also get low-dose radiation to the affected area. The goal is to see if this approach can improve the chance of complete remission while reducing long-term side effects. About 88 participants aged 21 or younger are enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Children's Hospital of Illinois at OSF St. Francis Medical Center

    Peoria, Illinois, 61637, United States

  • Dana-Farber Harvard Cancer Center

    Boston, Massachusetts, 02115, United States

  • Maine Children's Cancer Program (MCCP)

    Scarborough, Maine, 04074, United States

  • Packard Children's Hospital, Stanford University

    Palo Alto, California, 94304, United States

  • Rady Children's Hospital- San Diego

    San Diego, California, 92123, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

Conditions

Explore the condition pages connected to this study.